Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
01/2008
01/16/2008EP1877383A1 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity
01/16/2008EP1877380A1 Sulfonylamino(thio)carbonyl compounds in the form of herbicides or plant growth regulators
01/16/2008EP1877378A2 Oxindole compounds and their uses as therapeutic agents
01/16/2008EP1877377A2 Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles
01/16/2008EP1877376A1 Novel compounds for treating inflammatory diseases
01/16/2008EP1877052A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
01/16/2008EP1713778B1 Benzazepine derivatives as histamine h3 antagonists
01/16/2008EP1601659B1 Pyrimidin-2-one compounds and their use as dopamine d3 receptor ligands
01/16/2008EP1501809B1 Triazole derivatives as tachykinin receptor antagonists
01/16/2008EP1451154B1 Inhibitors of cytosolic phospholipase a2
01/16/2008EP0620003B1 Vasopressin antagonist and oxytocin antagonist
01/16/2008CN101107245A Heteroaryl substituted piperazinyl-pyridine analogues
01/16/2008CN101107233A 1H-imidiazole derivatives as cannabinoid CB2 receptor modulators
01/16/2008CN101104617A Dihydropyrimidine compounds and use for the same in preparing medicament for curing and preventing virosis
01/16/2008CN101104604A Optically pure dihydropyrimidine compounds and use for the same in preparing medicament for curing and preventing virosis
01/15/2008US7319111 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists
01/15/2008US7319104 hPPARs activators
01/15/2008US7319100 1-(1H-Pyrazin-2-on-3-yl)tetrahydroquinolines (3-(8-Bromo-6-methoxy-1,2,3,4-tetrahydroquinoline)-5-chloro-1-(1-ethylpropyl)-2(1H)-pyrazinone); treating anxiety and depression
01/15/2008US7319098 1,3-dioxoisoindole derivatives having selective antagonism of T-type calcium channel
01/15/2008US7318823 Methods for repairing damaged intervertebral discs
01/10/2008WO2008006040A1 Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors
01/10/2008WO2008006032A1 Cyclopenta [d] pyrimidines as akt protein kinase inhibitors
01/10/2008WO2008005511A2 Novel inhibitors of hepatitis c virus replication
01/10/2008WO2008005338A1 Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
01/10/2008WO2008004096A1 Pyrazole derivatives as cytochrome p450 inhibitors
01/10/2008WO2008003857A1 Pyrazolylbenzimidazole derivatives, compositions containing them and use thereof
01/10/2008WO2008003770A1 Phenyl substituted heteroaryl-derivatives and use thereof as anti-tumor agents
01/10/2008WO2008003665A1 Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group
01/10/2008WO2008003396A1 Indazole derivatives for treating hsp90-induced diseases
01/10/2008WO2007136680A3 3-pyraz0lyl-benzamide-4-ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
01/10/2008WO2007131764A3 New heterocyclic compounds for the inhibition of integrins and use thereof
01/10/2008WO2007123855A3 Pyrazolines for controlling invertebrate pests
01/10/2008WO2007123853A3 Five-membered heterocyclic invertebrate pest control agents
01/10/2008WO2007050425A3 Lxr modulators
01/10/2008US20080009635 tetrahydro-9-methyl-4H-carbazol-4-one/1,2,3,9-/ reacted with paraformaldehyde and dimethylamine or diisopropylamine to form an intermediate, reacting the intermediate with imidazole,-2-methyl in a aprotic polar solvent such as dimethylformamide, acetonitrile-pyrrolidone/2-/, n-methyl-
01/10/2008US20080009631 e.g. 2-[4-[3-[2-(2,4-Dichlorophenyl)-5-isopropyl-4-oxazolyl]propionyl]-2-methylphenoxy]-2-methylpropionic acid;
01/10/2008US20080009531 5-Anilino-4-Heteroarylpyrazole Derivatives Useful for the Treatment of Diabetes
01/10/2008US20080009525 Activator of peroxisome proliferator-activated receptor delta
01/10/2008US20080009506 Imidazole Compound
01/10/2008US20080009498 Phosphodiesterase inhibitors and nitric oxide donors, compositions and methods of use
01/10/2008US20080009497 Pyrrolotriazine kinase inhibitors
01/10/2008US20080009496 Mutagenic heterocycles
01/10/2008US20080009494 Cycloalkyl Substituted Pyrimidinediamine Compounds And Their Uses
01/10/2008US20080009493 Substituted Benzimidazoles and Imidazo-[4,5]-Pyridines
01/10/2008US20080009492 (2-Phenyl-1H-pyrrolo[2,3-b]pyridin-5-yl)-carbamic acid isopropyl ester, used in the control or prevention of illnesses such as cancer; anticarcinogenic agents
01/10/2008US20080009488 protein kinase inhibitors such as Methyl {5-[2-(5-chloro-2-methylphenyl)-1-hydroxy-3-oxo-2,3-dihydro-1H-isoindol-1-yl]-1H-benzimidazol-2-yl}carbamate, used to modulate cellular activities such as proliferation, differentiation, apoptosis, migration and chemoinvasion
01/10/2008US20080009479 Tetrahydrobenzazepines as Histamine H3 Receptor Ligands
01/10/2008US20080008760 Functionalized carbon nanotubes, a process for preparing the same and their use in medicinal chemistry
01/10/2008US20080008708 Tyrosine kinase inhibitors
01/10/2008CA2836316A1 Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors
01/10/2008CA2660031A1 Pyrazole derivatives as cytochrome p450 inhibitors
01/10/2008CA2657702A1 Quinazolines and related heterocyclic comp0unds, and their therapeutic use
01/10/2008CA2657035A1 Novel inhibitors of hepatitis c virus replication
01/10/2008CA2656622A1 Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors
01/10/2008CA2656618A1 Cyclopenta [d] pyrimidines as akt protein kinase inhibitors
01/10/2008CA2656458A1 Indazole derivatives for the treatment of hsp90-induced diseases
01/10/2008CA2654246A1 Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group
01/09/2008EP1874774A1 Combination product
01/09/2008EP1874770A1 Phenylacetamides suitable as protein kinase inhibitors
01/09/2008EP1874761A2 4h-1,2,4-triazin-5-one derivatives, their preparation and their use as alpha 7 nicotinic acetylcholine receptors
01/09/2008EP1874760A1 (lh-ind0l-7-yl)-( (pyrimidin-2 -yl-amino) methanone derivatives and related compounds as igf-rl inhibitors for treating cancer
01/09/2008EP1874739A1 Pharmaceutically active diazepanes
01/09/2008EP1874736A2 Fused heterocyclic compounds
01/09/2008EP1874734A1 1h-imidiazole derivatives as cannabinoid cb2 receptor modulators
01/09/2008EP1874732A1 Pyrazole derivatives as progesterone receptor antagonists
01/09/2008EP1874315A2 Compositions of novel opioid compounds and method of use thereof
01/09/2008EP1874304A2 Benzotriazole derivatives as cannabinoid receptor antagonists
01/09/2008EP1874303A1 Pyrazole compounds as prostaglandin receptors ligands
01/09/2008EP1711473B1 Substituted n-cyclohexylimidazolinones having an mch-modulatory effect
01/09/2008EP1653950B1 Nitrooxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-ii receptor blockers for the treatment of cardiovascular diseases
01/09/2008EP1385845B1 N-aroyl cyclic amines
01/09/2008EP1373218B1 Imidazolyl derivatives useful as histamine h3 receptor ligands
01/09/2008EP1239877B1 Composition comprising a tnf-alpha inhibitor and an integrin alphavbeta3 receptor antagonist
01/09/2008EP0850227B1 Pyridazin-3-one derivatives, their use, and intermediates for their production
01/09/2008CN101103028A Heteroaryl substituted quinolin-4-ylamine analogues
01/09/2008CN101103023A Disubstituted ureas as kinase inhibitors
01/09/2008CN101103022A New carboxylic acid amide used as XA inhititor
01/09/2008CN101103021A Preparation of crude candesartan cilexetil
01/09/2008CN101103016A Inhibitors of 11-beta hydroxyl steroid dehydrogenase type I and methods of using the same
01/09/2008CN101103015A 5-thioxo-1,5-dihydro-2h-pyrrol-2-one derivatives as liver X receptor modulators
01/09/2008CN101103014A N-heterocyclyl phthalic acid diamides as insecticides
01/09/2008CN101103005A Quinazoline derivatives, preparation methods and uses thereof
01/09/2008CN101103004A Novel cis-imidazolines
01/09/2008CN101103003A Novel heterocycle derivatives useful as selective androgen receptor modulators (SARMS)
01/09/2008CN101099740A Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
01/09/2008CN100360522C Novel compounds having selective inhibiting effect at GSK3
01/09/2008CN100360507C Inhibition of raf kinase using substituted heterocyclic ureas
01/09/2008CN100360505C Quinazoline derivatives as angiogenesis inhibitors
01/09/2008CN100360480C Amino group-containing chiral ionic liquid and its prepn process and application
01/08/2008US7317107 Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity
01/08/2008US7317102 Diarylmethyl and related compounds
01/08/2008US7317032 Imidazolyl inhibitors of 15-lipoxygenase
01/08/2008US7317013 such as N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-{4-[1-(2-hydroxyethyl)piperidin-4-yl]butyl} guanidine dihydrochloride and optionally with g-coupled receptor agonist or bronchodilators, used for promoting hydration of mucosal surfaces; improved pharmacokinetics
01/08/2008CA2414311C Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme
01/03/2008WO2008002974A1 Pyrrole derivatives and their methods of use
01/03/2008WO2008002674A2 Bicyclic compositions and methods for modulating a kinase cascade
01/03/2008WO2008002245A2 Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3)
01/03/2008WO2008002244A2 Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3)
01/03/2008WO2008002039A1 Quinazoline derivatives for inhibiting the growth of cancer cell
01/03/2008WO2008001886A1 Aurora inhibitor